Insider · CIK 0001704255

Engelhart James

Reports to the SEC for 1 company · NEW HAVEN, CT

sec.gov

Transactions

Companies

Filings

CIK

0001704255

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.D Disposition to Issuer	Strategic Advisor	DDisposition to Issuer	−15.9K sh	$148.50	−$2.36M	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardD Disposition to Issuer	Strategic Advisor	DDisposition to Issuer	−9,750 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardD Disposition to Issuer	Strategic Advisor	DDisposition to Issuer	−7,500 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardD Disposition to Issuer	Strategic Advisor	DDisposition to Issuer	−3,700 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Strategic Advisor	DDisposition to Issuer	−775 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Strategic Advisor	DDisposition to Issuer	−25.2K sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Strategic Advisor	DDisposition to Issuer	−2,398 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Strategic Advisor	DDisposition to Issuer	−27.6K sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Strategic Advisor	DDisposition to Issuer	−29.5K sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Strategic Advisor	DDisposition to Issuer	−71.9K sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Strategic Advisor	DDisposition to Issuer	−3,084 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Strategic Advisor	DDisposition to Issuer	−19.2K sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Strategic Advisor	DDisposition to Issuer	−59K sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Strategic Advisor	DDisposition to Issuer	−40K sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to buy)D Disposition to Issuer	Strategic Advisor	DDisposition to Issuer	−83.8K sh	—	—	0
2022-01-07	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Strategic Advisor	MExercise/Conversion	+3,250 sh	—	—	16,952
2022-01-07	Biohaven Pharmaceutical Holding Co Ltd.F Tax Payment	Strategic Advisor	FTax Payment	−1,279 sh	$128.87	−$165K	15,673
2022-01-07	Biohaven Pharmaceutical Holding Co Ltd.Employee Stock Option (Right to Buy)A Award	Strategic Advisor	AAward	+26K sh	—	—	26,000
2022-01-07	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardA Award	Strategic Advisor	AAward	+13K sh	—	—	13,000
2022-01-07	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardM Exercise/Conversion	Strategic Advisor	MExercise/Conversion	−3,250 sh	—	—	9,750
2022-01-06	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Strategic Advisor	MExercise/Conversion	+3,750 sh	—	—	15,234
2022-01-06	Biohaven Pharmaceutical Holding Co Ltd.F Tax Payment	Strategic Advisor	FTax Payment	−1,532 sh	$123.86	−$190K	13,702
2022-01-06	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardM Exercise/Conversion	Strategic Advisor	MExercise/Conversion	−3,750 sh	—	—	7,500
2021-12-10	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Strategic Advisor	MExercise/Conversion	+35K sh	—	—	46,196
2021-12-10	Biohaven Pharmaceutical Holding Co Ltd.S Sale	Strategic Advisor	SSale	−10.1K sh	$102.01	−$1.03M	36,065
2021-12-10	Biohaven Pharmaceutical Holding Co Ltd.S Sale	Strategic Advisor	SSale	−23.5K sh	$102.70	−$2.41M	12,578
2021-12-10	Biohaven Pharmaceutical Holding Co Ltd.S Sale	Strategic Advisor	SSale	−1,382 sh	$103.85	−$144K	11,196
2021-12-10	Biohaven Pharmaceutical Holding Co Ltd.Employee Stock Option (Right to Buy)M Exercise/Conversion	Strategic Advisor	MExercise/Conversion	−35K sh	—	—	83,792
2021-11-25	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Strategic Advisor	MExercise/Conversion	+3,700 sh	—	—	12,911
2021-11-25	Biohaven Pharmaceutical Holding Co Ltd.F Tax Payment	Strategic Advisor	FTax Payment	−1,715 sh	$115.55	−$198K	11,196
2021-11-25	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardM Exercise/Conversion	Strategic Advisor	MExercise/Conversion	−3,700 sh	—	—	3,700
2021-01-06	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Strategic Advisor	MExercise/Conversion	+3,750 sh	—	—	10,958
2021-01-06	Biohaven Pharmaceutical Holding Co Ltd.F Tax Payment	Strategic Advisor	FTax Payment	−1,747 sh	$83.38	−$146K	9,211
2021-01-06	Biohaven Pharmaceutical Holding Co Ltd.Employee Stock Option (right to buy)A Award	Strategic Advisor	AAward	+30K sh	—	—	30,000
2021-01-06	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardA Award	Strategic Advisor	AAward	+15K sh	—	—	15,000
2021-01-06	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardM Exercise/Conversion	Strategic Advisor	MExercise/Conversion	−3,750 sh	—	—	11,250
2020-11-25	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Strategic Advisor	MExercise/Conversion	+3,700 sh	—	—	8,222
2020-11-25	Biohaven Pharmaceutical Holding Co Ltd.F Tax Payment	Strategic Advisor	FTax Payment	−1,678 sh	$90.14	−$151K	6,544
2020-11-25	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardM Exercise/Conversion	Strategic Advisor	MExercise/Conversion	−3,700 sh	—	—	7,400
2020-06-11	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Strategic Advisor	MExercise/Conversion	+19.8K sh	$9.29	+$184K	24,294
2020-06-11	Biohaven Pharmaceutical Holding Co Ltd.S Sale	Strategic Advisor	SSale	−5,972 sh	$62.07	−$371K	18,322
2020-06-11	Biohaven Pharmaceutical Holding Co Ltd.S Sale	Strategic Advisor	SSale	−4,847 sh	$63.19	−$306K	13,475
2020-06-11	Biohaven Pharmaceutical Holding Co Ltd.S Sale	Strategic Advisor	SSale	−6,501 sh	$64.31	−$418K	6,974
2020-06-11	Biohaven Pharmaceutical Holding Co Ltd.S Sale	Strategic Advisor	SSale	−2,452 sh	$64.85	−$159K	4,522
2020-06-11	Biohaven Pharmaceutical Holding Co Ltd.Employee Stock Option (right to buy)M Exercise/Conversion	Strategic Advisor	MExercise/Conversion	−19.8K sh	—	—	0
2020-06-10	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Strategic Advisor	MExercise/Conversion	+11.5K sh	$9.29	+$106K	15,975
2020-06-10	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Strategic Advisor	MExercise/Conversion	+17.5K sh	$0.61	+$10.7K	33,475
2020-06-10	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Strategic Advisor	MExercise/Conversion	+25K sh	$5.60	+$140K	58,475
2020-06-10	Biohaven Pharmaceutical Holding Co Ltd.S Sale	Strategic Advisor	SSale	−28.8K sh	$66.66	−$1.92M	29,654
2020-06-10	Biohaven Pharmaceutical Holding Co Ltd.S Sale	Strategic Advisor	SSale	−24.8K sh	$67.53	−$1.68M	4,822

Recent filings

Accepted (ET)
Oct 34
Engelhart James0001562180-22-006955
SEC(opens sec.gov)
Jan 74
Engelhart James0001562180-22-000353
SEC(opens sec.gov)

Companies

Biohaven Pharmaceutical Holding Co Ltd.Strategic Advisor

Address

C/O BIOHAVEN PHARMACEUTICALS, INC. 234 CHURCH STREET

NEW HAVEN, CT, 06510